tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emma Nealon, 6 are a BUY (100%).
Analyst Emma Nealon, currently employed carries an average stock price target met ratio of 13.33% that have a potential upside of 53.8% achieved within 53 days.
Emma Nealon’s has documented 23 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on EQ, Equillium at 14-Aug-2023.
Analyst best performing recommendations are on EQ (EQUILLIUM).
The best stock recommendation documented was for EQ (EQUILLIUM) at 8/14/2023. The price target of $2.8 was fulfilled within 190 days with a profit of $2.01 (254.43%) receiving and performance score of 13.39.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$49
2 years 3 months 24 days ago
(02-Sep-2022)
0/3 (0%)
$39.17 (398.47%)
Hold
$20
$-0.01 (-0.05%)
$40
2 years 3 months 24 days ago
(02-Sep-2022)
1/2 (50%)
$0.02 (0.10%)
41
Hold
$20
$-0.01 (-0.05%)
$64
2 years 3 months 24 days ago
(02-Sep-2022)
1/2 (50%)
$0.02 (0.10%)
41
Hold
$20
$-0.01 (-0.05%)
$53
2 years 3 months 24 days ago
(02-Sep-2022)
1/4 (25%)
$0.02 (0.10%)
41
Buy
$23
$2.99 (14.94%)
$40
2 years 6 months 29 days ago
(27-May-2022)
0/4 (0%)
$17.23 (298.61%)
What Year was the first public recommendation made by Emma Nealon?
